Ranibizumab Biosimilar, Human VEGF Monoclonal Antibody Fragment (Fab)

Ranibizumab Biosimilar, Human VEGF Monoclonal Antibody Fragment (Fab)

$700.00$1,750.00

In stock

$700.00$1,750.00

Ranibizumab Biosimilar, Human VEGF Monoclonal Antibody Fragment (Fab). Ranibizumab biosimilar E.coli cell line is available for licensing to manufacture the Fab protein ranibizumab.The research grade ranizumab biosimilar protein is for research use only (RUO). Recombinant human IgG1 isotype controls are available.

SKU: C005P
Clear
View cart
Catalog No. C005P
Product NameRanibizumab Biosimilar, Human VEGF Monoclonal Antibody Fragment (Fab)
Supplier Name Syd Labs, Inc.
Brand Name Syd Labs
Synonyms Anti-VEGF-A Humanized Monoclonal Antibody (Fab)
Summary Recombinant Humanized Monoclonal Antibody Fragment (Fab) generated from the same parent mouse antibody as bevacizumab.
Source/Host The research grade Fab protein ranibizumab was produced in the ranibizumab biosimilar E.coli cell line.
Specificity/Sensitivity The Fab protein ranibizumab specifically binds to the human VEGF-A.
Applications Functional assay, neutralization.
Form Of Antibody 0.2 uM filtered solution, pH 5.3, no stabilizers or preservatives.
Endotoxin < 1 EU per 1 mg of the protein by the LAL method.
Purity >95% by SDS-PAGE under reducing conditions and HPLC.
Shipping The Fab protein ranibizumab is shipped with ice pack. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70°C as supplied. 1 month from date of receipt, 2 to 8°C as supplied.
Note Ranibizumab biosimilar E.coli cell line is available for licensing to manufacture the Fab protein ranibizumab.The research grade ranizumab biosimilar protein is for research use only (RUO). Recombinant human IgG1 isotype controls are available.
Order Offline Phone: 1-617-401-8149 Fax: 1-617-606-5022 Email: message@sydlabs.com Orleave a message with a formal purchase order (PO) Or credit card.

Description

C005P: Ranibizumab Biosimilar, Human VEGF Monoclonal Antibody Fragment (Fab)

Recombinant Humanized Monoclonal Antibody Fragment (Fab) generated from the same parent mouse antibody as bevacizumab.

Background

The humanized anti-VEGF-A monoclonal antibody drug Bevacizumab (trade name Avastin, Genentech/Roche) is the first clinically available angiogenesis inhibitor in the United States. The humanized anti-VEGF-A monoclonal antibody fragment (Fab) Ranibizumab (trade name Lucentis, Genentech) is derived from the same parent mouse antibody as bevacizumab. Both antibody drugs produce angiogenesis inhibition and slow the growth of new blood vessels. Ranibizumab is much smaller than the parent complete antibody but shows stronger binding to VEGF-A after affinity maturation. Ranibizumab can also be used to treat the “wet” type of age-related macular degeneration (AMD, also ARMD), a common form of age-related vision loss.

Vascular endothelial growth factor A (VEGF-A) stimulates angiogenesis in a variety of cancers, including colorectal, lung, breast, glioblastoma, kidney, and ovarian cancers.

Syd Labs also provides the following VEGF-A antibody biosimilar protein:
Bevacizumab Biosimilar (complete antibody produced in CHO)

Syd Labs also provides the following research grade antibody biosimilar proteins:
Bevacizumab Biosimilar, research grade (VEGF-A)
Ranibizumab Biosimilar, research grade (VEGF-A, Fab produced in E. coli)
Cetuximab Biosimilar, research grade (HER1, ErbB-1, EGFR)
Panitumumab Biosimilar, research grade (HER1, ErbB-1, EGFR)
Trastuzumab Biosimilar, research grade (HER2, ErbB-2, c-neu)
Pertuzumab Biosimilar, research grade (HER2, ErbB-2, c-neu)
Infliximab biosimilar, research grade (TNF alpha)
Adalimumab biosimilar, research grade (TNF alpha)
Rituximab biosimilar, research grade (CD20)
Denosumab biosimilar, research grade (RANKL, RANK ligand, OPGL, TNFSF11, CD254, TRANCE, ODF)
Palivizumab Biosimilar, research grade (RSV)
Omalizumab biosimilar, research grade (IgE)
Eculizumab biosimilar, research grade (C5)

Please remember our product information: Ranibizumab Biosimilar, Human VEGF Monoclonal Antibody Fragment (Fab): C005P Syd Labs

Additional information

Ship from Country

USA

Size

10 mg, 2 mg

No more offers for this product!